Header Logo

Connection

PETER JONES to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications PETER JONES has written about Clinical Trials, Phase II as Topic.
PETER JONES
Connection Strength
0.131
Clinical Trials, Phase II as Topic
  1. Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. Am J Cardiol. 2016 Dec 15; 118(12):1805-1811.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.